Rosalba Minelli Selected Research

pyrimidine

11/2019

Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosalba Minelli Research Topics

Disease

19	Neoplasms (Cancer) 07/2021 - 06/2010
4	Neoplasm Metastasis (Metastasis) 11/2019 - 10/2010
4	Lung Neoplasms (Lung Cancer) 11/2019 - 03/2015
4	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 01/2011
3	Colonic Neoplasms (Colon Cancer) 01/2012 - 06/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 09/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019 - 03/2015
2	Carcinogenesis 01/2016 - 03/2015
2	Melanoma (Melanoma, Malignant) 12/2015 - 12/2013
1	Disease Progression 11/2019
1	Adenocarcinoma 11/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Carcinoma (Carcinomatosis) 09/2010

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 10/2010
5	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2015 - 09/2010
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 03/2015
3	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2019
3	CyclodextrinsIBA 01/2016 - 11/2012
3	LigandsIBA 05/2014 - 06/2010
2	Zinc Finger E-box-Binding Homeobox 1IBA 01/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 01/2019
2	Histone Deacetylase InhibitorsIBA 01/2019 - 01/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 10/2011
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2016 - 11/2012
2	CamptothecinIBA 01/2016 - 11/2012
2	AldehydesIBA 03/2015 - 12/2013
2	Rosiglitazone (Avandia)FDA Link 01/2012 - 06/2010
2	1,3- benzothiazol- 2- yl(2- ((2- (3- pyridinyl)ethyl)amino)- 4- pyrimidinyl)acetonitrileIBA 01/2012 - 01/2012
2	Telomerase (Telomerase Reverse Transcriptase)IBA 09/2010 - 06/2010
1	pevonedistatIBA 07/2021
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 07/2021
1	Cyclin-Dependent Kinase 4IBA 01/2021
1	Cadherins (E-Cadherin)IBA 11/2019
1	Transcription Factors (Transcription Factor)IBA 11/2019
1	Mi-2 Nucleosome Remodeling and Deacetylase ComplexIBA 11/2019
1	NucleotidesIBA 11/2019
1	pyrimidineIBA 11/2019
1	Decitabine FDA Link 11/2019
1	Immune Checkpoint InhibitorsIBA 04/2019
1	Mitogen-Activated Protein KinasesIBA 01/2019
1	Interleukin-17 ReceptorsIBA 01/2019
1	mocetinostatIBA 01/2019
1	AlkaloidsIBA 01/2016
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2016
1	NanocapsulesIBA 12/2015
1	immune RNA (I-RNA)IBA 10/2015
1	Inosine FDA Link 10/2015
1	Adenosine (Adenocard)FDA LinkGeneric 10/2015
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 03/2015
1	CollagenIBA 03/2015
1	Lysine (L-Lysine)FDA Link 03/2015
1	HydroxylysineIBA 03/2015
1	ChitosanIBA 01/2014
1	Fluorouracil (Carac)FDA LinkGeneric 01/2014
1	Topoisomerase I InhibitorsIBA 11/2012
1	AndrogensIBA 11/2012
1	ciprofibrateIBA 01/2012
1	Fibric Acids (Fibrates)IBA 01/2012
1	Clofibrate FDA Link 01/2012
1	PanobinostatIBA 01/2011
1	Antineoplastic Agents (Antineoplastics)IBA 01/2011
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2010
1	PPAR gammaIBA 06/2010
1	Peroxisome ProliferatorsIBA 06/2010

Therapy/Procedure

5	Therapeutics 07/2021 - 10/2011
1	Precision Medicine 01/2016
1	Topical Administration 12/2015
1	Nanospheres 01/2014